drugset / Trial / NCT02535156
Schizotypal Personality Disorder Risperidone
Non-randomizedCrossoverDouble-blindBasic science
Summary
Neurophysiological indices of self-monitoring were assessed in a group of patients with Schizotypal Personality Disorder (SPD) and a control group. Both groups were assessed after the administration of risperidone and placebo.
Timeline
- Start
- 2003-01
- Primary completion
- 2014-01
- Completion
- 2015-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Risperidone | Other / unclassified | 1 mg | — |